Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial. (2023)

First Author: Menon U
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3310/bhbr5832

PubMed Identifier: 37183782

Publication URI: http://europepmc.org/abstract/MED/37183782

Type: Journal Article/Review

Parent Publication: Health technology assessment (Winchester, England)

ISSN: 1366-5278